Hobsley M, Tovey F. Helicobacter pylori: the primary cause of duodenal ulceration or a secondary infection? World J Gastroenterol 2001; 7(2): 149-151 [PMID: 11819753 DOI: 10.3748/wjg.v7.i2.149]
Corresponding Author of This Article
Professor M. Hobsley, Department of Surgery, Royal Free and University College Medical School, London, 67-73 Riding House Street, London, WIP 7LD, United Kingdom.hobsley@ucl.ac.uk
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
M Hobsley, FI Tovey, Department of Surgery, Royal Free and University College Medical School, London, 67-73 Riding House Street, London, WIP 7LD, United Kingdom
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed equally to the work.
Correspondence to: Professor M. Hobsley, Department of Surgery, Royal Free and University College Medical School, London, 67-73 Riding House Street, London, WIP 7LD, United Kingdom.hobsley@ucl.ac.uk
Telephone: 0208-445-6507 Fax: 0208-492-0317
Received: March 18, 2001 Revised: March 22, 2001 Accepted: March 24, 2001 Published online: April 15, 2001
Citation: Hobsley M, Tovey F. Helicobacter pylori: the primary cause of duodenal ulceration or a secondary infection? World J Gastroenterol 2001; 7(2): 149-151
It is generally accepted that Helicobacter pylori (H. pylori) infection has a role in duodenal ulceration. Eradication of H. pylori accelerates healing compared with placebo in the absence of control of gastric secretion and reduces ulcer recurrence. There is increasing evidence, however, that it may not be the primary cause of duodenal ulceration, but that it may be a secondary factor in a number of cases. This possibility is supported by four sets of observations.
Geographical distribution
In India and China there is a difference in prevalence of duodenal ulceration between the rice eating areas of the south and the drier wheat and millet eating areas of the north despite a similar high prevalence of H. pylori infection[1-3]. There is a similar situation along the West Coast of Africa. In the coastal area in the south where there is a diet of yams, sweet potato, manioc, plantains, rice and some white flour, the prevalence of duodenal ulceration is higher than in the northern savannah regions where much of the diet is millet. Both areas have a similar prevalence of H. pylori infection[4,5]. Again in Fiji the Indian population adhering to their traditional diet has twice the incidence of duodenal ulceration compared to the Fijian population despite similar H. pylori infection rates[6,7].
H. pylori-negative duodenal ulceration
There are many reports of H. pylori -negative duodenal ulceration unrelated to non-steroidal anti-inflammatory drugs (NSAIDs) varying in prevalence between 14% and 72% (Table 1)[8-26]. The figures from more developed countries suggest that H. pylori-negative duodenal ulceration occurs more frequently in areas where the overall prevalence of H. pylori infection in the community is low[20,27]. A paper from Greater Rochester, New York[11], reports a 48% prevalence of H. pylori-negative in white patients and 15% in non-white, with an overall prevalence of 39%. Parsonnet[28] has conducted a world-wide survey of reports and gives a figure of 40% H. pylori negative duodenal ulcers. Kurata et al[27] calculated that only between 48% and 64% of peptic ulcers are H. pylori-positive.
Table 1 Endoscopy reports of Helicobacter pylori-negative duodenal ulcer (DU) unrelated to NSAIDs.
Early cases of duodenal ulceration may be H. pylori-negative
Dres Pest[29] from Argentina found a 78% incidence of H. pylori infection in patients with a history of chronic ulceration and only 41% in patients with a short history. He suggests that many patients with a short history may be free from H. pylori infection.
Recurrence after eradication
Laine et al[30] from N. America have done a meta-analysis of seven trials subjected to strict criteria and report a recurrent duodenal ulcer rate of 20% within 6 months of H. pylori eradication in patients not on NSAIDs. Two other reports[31,32] excluding NSAIDs give figures of a 6% endoscopic recurrence within 3 years and of 18.9% clinical relapse within 7 years after eradication in patients remaining H. pylori negative. There are many other reports of recurrent ulceration in patients remaining H. pylori negative after eradication in which NSAID users have not been excluded.
DISCUSSION
The above findings strongly suggest that H. pylori infection is not a prerequisite for duodenal ulceration and that H. pylori infection when it occurs may be only a secondary factor.
It has been suggested that the differences mentioned in the geographical distribution of duodenal ulcer may be due to the higher prevalence of Cag A and Vac A virulent strains of H. pylori in these areas, but there is no evidence to support this[33-39].
The long held concept that duodenal ulceration is the result of a combination of increased acid output together with factors such as reduced bicarbonate in the duodenum reducing the ability of the duodenum to cope with the presenting acid level still remains valid. There may be other factors-smoking, genetic or dietary. Smoking has a chronic effect of increasing the ability to secrete acid[40]. There is convincing evidence that the differences in geographical or ethnic distribution of duodenal ulceration may be diet related[41,42]. Duodenal ulceration is less common in areas where unrefined wheat, certain pulses and millets form the staple diet and more common in areas where rice, refined maize or wheat flour, yams, manioc, plantains or sweet potatoes are the staple foods. Experiments in our laboratory on animal peptic ulcer models have confirmed the protective action against ulceration of the lipids present in certain food from areas of low duodenal ulcer prevalence and have shown that stored milled white rice and its oil are ulcerogenic[43-46]. There are several reports[47-62] showing the protective effect of certain dietary essential fatty acids, phospholipids and phytosterols against peptic ulceration in several experimental animal models.
In conclusion, the findings suggest that duodenal ulceration does occur independently of H. pylori infection and that H. pylori infection which may be coincidental or be acquired subsequently contributes to the chronicity of the ulceration. Subsequent infection is more likely to occur in areas where the prevalence of H. pylori infection is high. Treatment reducing acid secretion and raising the pH may contribute to H. pylori infection in ulcer patients.
This is presented as a paper for discussion and it is hoped that readers will respond with their points of view in the correspondence section of the journal.
ACKNOWLEDGEMENTS
We acknowledge permission from the Journal of Gastroenterology and Hepatology to use material in Table 1 which was previously published in their journal(1999;14:1053-1056)
Beg F, Oldmeadow M, Morris A, Miller M, Nicholson G. Campylobacter pylori infection in patients undergoing endoscopy in Fiji.N Z Med J. 1988;101:140-141.
[PubMed] [DOI][Cited in This Article: ]
Oshowo AO. The direction of relationship between Helicobacter pylori and duodenal ulceration.MSc thesis, Uni-versity of London. 1999;.
[PubMed] [DOI][Cited in This Article: ]
Maher W, Jyotheeswaran S, Potter G. An epidemiological study of peptic ulcer disease patients in Greater Rochester, New York.Gastroenterology. 1997;112:A206.
[PubMed] [DOI][Cited in This Article: ]
Greenberg PD, Albert CM, Ridker PM. Helicobacter pylori as a risk factor for peptic ulcer in patients taking low dose aspirin.Gastroenterology. 1997;112:A113.
[PubMed] [DOI][Cited in This Article: ]
Gislason GT, Emu B, Okolo III P, Pasricha PJ, Kalloo AM. Where have all the Helicobacter gone Etiologic factors in patients with duodenal ulcers presenting to a University Hospital.Gastrointest Endosc. 1997;45:A263.
[PubMed] [DOI][Cited in This Article: ]
Fenger HJ, Gudmand-Høyer E. Peptic ulcer in Greenland Inuit: evidence for a low prevalence of duodenal ulcer.Int J Circumpolar Health. 1997;56:64-69.
[PubMed] [DOI][Cited in This Article: ]
Azim Mirghani YA, Ahmed S, Ahmed M, Ismail MO, Fedail SS, Kamel M, Saidia H. Detection of Helicobacter pylori in endoscopic biopsies in Sudan.Trop Doct. 1994;24:161-163.
[PubMed] [DOI][Cited in This Article: ]
Kontou M, Katelaris PM. The prevalence of Helicobacter pylori and the spectrums of gastroduodenal ulcers in a cohort of Australian dyspeptic patients.Gut. 1997;41:A37.
[PubMed] [DOI][Cited in This Article: ]
Lanza F, Ciociola AA, Sykes DL, Heath A, McSorley DJ, Webb DD. Ranitidine Bi citrate plus clarithromycin is effective in eradi-cating Helicobacter pylori: healing duodenal ulcer and preventing ulcer relapse.Gastroenterology. 1996;110:A172.
[PubMed] [DOI][Cited in This Article: ]
Bruno JM, Jones HP, Kubik CM, Gmettinger JK. The low preva-lence of Helicobacter pylori in a military treatment facility.Gastroenterology. 1997;112:A79.
[PubMed] [DOI][Cited in This Article: ]
Sprung DJ, Gano B. The natural history of duodenal ulcer disease and how it relates to Helicobacter pylori.Am J Gastroenterol. 1997;92:1655(Abstract).
[PubMed] [DOI][Cited in This Article: ]
Lahaie RG, Lahaie M, Boivin M, Gagnon M, Lemoyne M, Nguyen B, Plourde V, Poitras P, Sahai A. Changing prevalence of Helicobacter pylori infection in endoscopically demonstrated duodenal ulcer.Gut. 2000;47:A77-78.
[PubMed] [DOI][Cited in This Article: ]
Pest P, Zárate J, Varsky C, Man F, Schraier M. Helicobacter pylori in recently-diagnosed versus chronic duodenal ulcer.Acta Gastroenterol Latinoam. 1996;26:273-276.
[PubMed] [DOI][Cited in This Article: ]
Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated A meta-analysis of rigorously designed trials.Am J Gastroenterol. 1998;93:1409-1415.
[PubMed] [DOI][Cited in This Article: ]
Martino G, Paoletti M, Marcheggiano A, D'Ambra G, Delle Fave G, Annibale B. Duodenal ulcer relapse is not always associated with recurrence of H. pylori infection: a prospective three-year follow-up study.Helicobacter. 1999;4:213-217.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 11][Cited by in RCA: 11][Article Influence: 0.4][Reference Citation Analysis (0)]
Pérez-Pérez GI, Bhat N, Gaensbauer J, Fraser A, Taylor DN, Kuipers EJ, Zhang L, You WC, Blaser MJ. Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections.Int J Cancer. 1997;72:453-456.
[PubMed] [DOI][Cited in This Article: ][Cited by in RCA: 2][Reference Citation Analysis (0)]
Pan ZJ, van der Hulst RW, Feller M, Xiao SD, Tytgat GN, Dankert J, van der Ende A. Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia.J Clin Microbiol. 1997;35:1344-1347.
[PubMed] [DOI][Cited in This Article: ]
Rocha AM, Rocha GA, de Magalhães Queiroz DM, Ani AE, Okeke EN, Bello CS, Malu AO. Anti-CagA antibodies in Helicobacter pylori-positive patients and blood donors from Nigeria.Trop Doct. 2001;31:147-149.
[PubMed] [DOI][Cited in This Article: ]
Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, Shiratori Y, Omata M. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan.Gut. 1998;42:338-343.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 166][Cited by in RCA: 182][Article Influence: 6.7][Reference Citation Analysis (0)]
Maeda S, Kanai F, Ogura K, Yoshida H, Ikenoue T, Takahashi M, Kawabe T, Shiratori Y, Omata M. High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan.Dig Dis Sci. 1997;42:1841-1847.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 47][Cited by in RCA: 47][Article Influence: 1.7][Reference Citation Analysis (0)]
Ogura K, Kanai F, Maeda S, Yoshida H, Ogura M, Lan KH, Hirota K, Kawabe T, Shiratori Y, Omata M. High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan.Gut. 1997;41:463-468.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 27][Cited by in RCA: 34][Article Influence: 1.2][Reference Citation Analysis (0)]
Jayaraj AP, Rees KR, Tovey FI, White JS. A molecular basis of peptic ulceration due to diet.Br J Exp Pathol. 1986;67:149-155.
[PubMed] [DOI][Cited in This Article: ]
Tarnawski A, Hollander D, Gergely H. Protection of the gastric mucosa by linoleic acid--a nutrient essential fatty acid.Clin Invest Med. 1987;10:132-135.
[PubMed] [DOI][Cited in This Article: ]
Lichtenberger LM, Romero JJ, Kao YC, Dial EJ. Gastric protective activity of mixtures of saturated polar and neutral lipids in rats.Gastroenterology. 1990;99:311-326.
[PubMed] [DOI][Cited in This Article: ]
Lichtenberger LM, Romero JJ, Kao YCJ, Dial EJ. Gastric protective actions of a unique mixture of phospholipid and neutral lipid.Gastroenterology. 1990;98:A78 (Abstract).
[PubMed] [DOI][Cited in This Article: ]
Ghosal S, Saini KS. Sitoindosides I and II. Two new anti ulcerogenic teryl acyl glycosides from Musa Paradisiaca.J Chem Res. 1984;S:110, 1984; M: 965-975.
[PubMed] [DOI][Cited in This Article: ]